PMID- 34889771 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220111 IS - 1929-0748 (Print) IS - 1929-0748 (Electronic) IS - 1929-0748 (Linking) VI - 10 IP - 12 DP - 2021 Dec 9 TI - Health Impacts and Characteristics of Deprescribing Interventions in Older Adults: Protocol for a Systematic Review and Meta-analysis. PG - e25200 LID - 10.2196/25200 [doi] LID - e25200 AB - BACKGROUND: Deprescribing, a relatively recent concept, has been proposed as a promising solution to the growing issues of polypharmacy and use of medications of questionable benefit among older adults. However, little is known about the health outcomes of deprescribing interventions. OBJECTIVE: This paper presents the protocol of a study that aims to contribute to the knowledge on deprescribing by addressing two specific objectives: (1) describe the impact of deprescribing in adults >/=60 years on health outcomes or quality of life; and (2) determine the characteristics of effective interventions in deprescribing. METHODS: Primary studies targeting three concepts (older adults, deprescribing, and health or quality of life outcomes) will be included in the review. The search will be performed using key international databases (MEDLINE, EMBASE, CINAHL, Ageline, PsycInfo), and a special effort will be made to identify gray literature. Two reviewers will independently screen the articles, extract the information, and evaluate the quality of the selected studies. If methodologically feasible, meta-analyses will be performed for groups of intervention studies reporting on deprescribing interventions for similar medications, used for similar or identical indications, and reporting on similar outcomes (eg, benzodiazepines used against insomnia and studies reporting on quality of sleep or quality of life). Alternatively, the results will be presented in bottom-line statements (objective 1) and a matrix outlining effective interventions (objective 2). RESULTS: The knowledge synthesis may be limited by the availability of high-quality clinical trials on deprescribing and their outcomes in older adults. Additionally, analyses will likely be affected by studies on the deprescribing of different types of molecules within the same indication (eg, different pharmacological classes and medications to treat hypertension) and different measures of health and quality of life outcomes for the same indication. Nevertheless, we expect the review to identify which deprescribing interventions lead to improved health outcomes among seniors and which of their characteristics contribute to these outcomes. CONCLUSIONS: This systematic review will contribute to a better understanding of the health outcomes of deprescribing interventions among seniors. TRIAL REGISTRATION: PROSPERO International Prospective Register of Systematic Reviews CRD42015020866; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42015020866. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/25200. CI - (c)Zoe Tremblay, David Mumbere, Danielle Laurin, Caroline Sirois, Daniela Furrer, Lise Poisblaud, Pierre-Hugues Carmichael, Barbara Farrell, Andre Tourigny, Anik Giguere, Isabelle Vedel, Jose Morais, Edeltraut Kroger. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 09.12.2021. FAU - Tremblay, Zoe AU - Tremblay Z AUID- ORCID: 0000-0003-3194-3688 AD - Faculte de pharmacie, Universite Laval, Quebec, QC, Canada. FAU - Mumbere, David AU - Mumbere D AUID- ORCID: 0000-0002-6746-9300 AD - Faculte de pharmacie, Universite Laval, Quebec, QC, Canada. FAU - Laurin, Danielle AU - Laurin D AUID- ORCID: 0000-0001-5032-2452 AD - Faculte de pharmacie, Universite Laval, Quebec, QC, Canada. FAU - Sirois, Caroline AU - Sirois C AUID- ORCID: 0000-0003-3294-7883 AD - Faculte de pharmacie, Universite Laval, Quebec, QC, Canada. FAU - Furrer, Daniela AU - Furrer D AUID- ORCID: 0000-0002-1497-1831 AD - Centre d'excellence sur le vieillissement de Quebec, Centre integre universitaire de sante et de services sociaux de la Capitale Nationale, Quebec, QC, Canada. FAU - Poisblaud, Lise AU - Poisblaud L AUID- ORCID: 0000-0001-9737-7178 AD - Centre d'excellence sur le vieillissement de Quebec, Centre integre universitaire de sante et de services sociaux de la Capitale Nationale, Quebec, QC, Canada. FAU - Carmichael, Pierre-Hugues AU - Carmichael PH AUID- ORCID: 0000-0002-5324-862X AD - Centre d'excellence sur le vieillissement de Quebec, Centre integre universitaire de sante et de services sociaux de la Capitale Nationale, Quebec, QC, Canada. FAU - Farrell, Barbara AU - Farrell B AUID- ORCID: 0000-0002-2388-5353 AD - Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. FAU - Tourigny, Andre AU - Tourigny A AUID- ORCID: 0000-0002-2447-8848 AD - Faculte de medecine, Universite Laval, Quebec, QC, Canada. FAU - Giguere, Anik AU - Giguere A AUID- ORCID: 0000-0001-9928-7395 AD - Faculte de medecine, Universite Laval, Quebec, QC, Canada. FAU - Vedel, Isabelle AU - Vedel I AUID- ORCID: 0000-0002-6873-1681 AD - Faculty of Medicine, McGill University, Montreal, QC, Canada. FAU - Morais, Jose AU - Morais J AUID- ORCID: 0000-0001-9366-6626 AD - Faculty of Medicine, McGill University, Montreal, QC, Canada. FAU - Kroger, Edeltraut AU - Kroger E AUID- ORCID: 0000-0002-5653-3979 AD - Faculte de pharmacie, Universite Laval, Quebec, QC, Canada. AD - Centre d'excellence sur le vieillissement de Quebec, Centre integre universitaire de sante et de services sociaux de la Capitale Nationale, Quebec, QC, Canada. AD - Faculty of Medicine, McGill University, Montreal, QC, Canada. LA - eng PT - Journal Article DEP - 20211209 PL - Canada TA - JMIR Res Protoc JT - JMIR research protocols JID - 101599504 PMC - PMC8704115 OTO - NOTNLM OT - aging OT - comorbidity OT - deprescribing OT - inappropriate prescribing OT - medication use OT - multimorbidity OT - older adult OT - polypharmacy OT - potentially inappropriate medication OT - systematic review COIS- Conflicts of Interest: None declared. EDAT- 2021/12/11 06:00 MHDA- 2021/12/11 06:01 PMCR- 2021/12/09 CRDT- 2021/12/10 12:17 PHST- 2020/10/21 00:00 [received] PHST- 2021/09/03 00:00 [accepted] PHST- 2021/08/05 00:00 [revised] PHST- 2021/12/10 12:17 [entrez] PHST- 2021/12/11 06:00 [pubmed] PHST- 2021/12/11 06:01 [medline] PHST- 2021/12/09 00:00 [pmc-release] AID - v10i12e25200 [pii] AID - 10.2196/25200 [doi] PST - epublish SO - JMIR Res Protoc. 2021 Dec 9;10(12):e25200. doi: 10.2196/25200.